Stephen J. Forman
2023
In 2023, Stephen J. Forman earned a total compensation of $70.6K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $22,500 |
| Total | $70,631 |
Forman received $48.1K in option awards, accounting for 68% of the total pay in 2023.
Forman also received $22.5K in other compensation.
Rankings
In 2023, Stephen J. Forman's compensation ranked 2,936th out of 3,006 executives tracked by ExecPay. In other words, Forman earned more than 2.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,936 out of 3,006 | 2nd |
Division Manufacturing | 1,626 out of 1,650 | 2nd |
Major group Chemicals And Allied Products | 904 out of 918 | 2nd |
Industry group Drugs | 868 out of 881 | 2nd |
Industry Pharmaceutical Preparations | 627 out of 637 | 2nd |
Source: SEC filing on November 4, 2024.
Forman's colleagues
We found four more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.